BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bai H, Yang J, Cao D, Huang H, Xiang Y, Wu M, Cui Q, Chen J, Lang J, Shen K. Ovary and uterus-sparing procedures for low-grade endometrial stromal sarcoma: a retrospective study of 153 cases. Gynecol Oncol. 2014;132:654-660. [PMID: 24412112 DOI: 10.1016/j.ygyno.2013.12.032] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Yu HY, Jin YL. Metastatic low-grade endometrial stromal sarcoma with variable morphologies in the ovaries and mesentery: A case report. World J Clin Cases 2022; 10(23): 8384-8391 [DOI: 10.12998/wjcc.v10.i23.8384] [Reference Citation Analysis]
2 Borella F, Bertero L, Cassoni P, Piovano E, Gallio N, Preti M, Cosma S, Ferraioli D, Pace L, Mariani L, Biglia N, Benedetto C. Low-Grade Uterine Endometrial Stromal Sarcoma: Prognostic Analysis of Clinico-Pathological Characteristics, Surgical Management, and Adjuvant Treatments. Experience From Two Referral Centers. Front Oncol 2022;12:883344. [DOI: 10.3389/fonc.2022.883344] [Reference Citation Analysis]
3 Roy M, Musa F, Taylor SE, Huang M. Uterine Sarcomas: How to Navigate an Ever-Growing List of Subtypes. Am Soc Clin Oncol Educ Book 2022;42:1-10. [PMID: 35471831 DOI: 10.1200/EDBK_350955] [Reference Citation Analysis]
4 Chen J, Wang J, Cao D, Yang J, Huang H, Pan L, Xiang Y. Low-grade endometrial stromal sarcoma with intracaval or intracardiac extension: a retrospective study of eight cases. Arch Gynecol Obstet. [DOI: 10.1007/s00404-021-06373-4] [Reference Citation Analysis]
5 Bai H, Yuan F, Liang B, Sun H, Gao Y, Jin M, Xing X. Clinicopathological characteristics and treatment of patients with high-grade endometrial stromal sarcoma: A retrospective study of 40 cases. Medicine (Baltimore) 2022;101:e28490. [PMID: 35029198 DOI: 10.1097/MD.0000000000028490] [Reference Citation Analysis]
6 Dondi G, Porcu E, De Palma A, Damiano G, De Crescenzo E, Cipriani L, Dirodi M, Ravegnini G, De Leo A, Nannini M, Ferioli M, Morganti AG, Pantaleo MA, De Iaco P, Perrone AM. Uterine Preservation Treatments in Sarcomas: Oncological Problems and Reproductive Results: A Systematic Review. Cancers (Basel) 2021;13:5808. [PMID: 34830960 DOI: 10.3390/cancers13225808] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
7 Matsukawa H, Ota N, Nishioka K, Noguchi T, Iwahashi N, Mabuchi Y, Yagi S, Minami S, Ino K. Low-grade endometrial stromal sarcoma in a young woman diagnosed after resection of endometrial polyp-like lesions: A case report. Mol Clin Oncol 2021;15:236. [PMID: 34650803 DOI: 10.3892/mco.2021.2400] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Nasioudis D, Mastroyannis SA, Latif NA, Ko EM, Haggerty AF, Kim SH, Morgan MA, Giuntoli RL 2nd. Role of lymphadenectomy for apparent early stage uterine sarcoma; a comprehensive analysis of the National Cancer Database. Surg Oncol 2021;38:101589. [PMID: 33957499 DOI: 10.1016/j.suronc.2021.101589] [Reference Citation Analysis]
9 Dai Q, Xu B, Wu H, You Y, Wu M, Li L. The prognosis of recurrent low-grade endometrial stromal sarcoma: a retrospective cohort study. Orphanet J Rare Dis 2021;16:160. [PMID: 33827628 DOI: 10.1186/s13023-021-01802-8] [Reference Citation Analysis]
10 Gu YZ, Duan NY, Cheng HX, Xu LQ, Meng JL. Fertility-sparing surgeries without adjuvant therapy through term pregnancies in a patient with low-grade endometrial stromal sarcoma: A case report. World J Clin Cases 2021; 9(4): 983-991 [PMID: 33585648 DOI: 10.12998/wjcc.v9.i4.983] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Horn LC, Höhn AK, Denschlag D, Follmann M, Schmidt D. [Interdisciplinary S2k guidelines on the diagnosis and treatment of uterine sarcomas-recommendations for surgical pathology]. Pathologe 2020;41:621-33. [PMID: 32940744 DOI: 10.1007/s00292-020-00826-4] [Reference Citation Analysis]
12 Ayhan A, Toptas T, Oz M, Vardar MA, Kayikcioglu F, Ozgul N, Gokcu M, Simsek T, Tunc M, Meydanli MM. Low-grade endometrial stromal sarcoma: A Turkish uterine sarcoma group study analyzing prognostic factors and disease outcomes. Gynecol Oncol 2021;160:674-80. [PMID: 33375988 DOI: 10.1016/j.ygyno.2020.12.017] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Cabrera S, Bebia V, Acosta U, Franco-Camps S, Mañalich L, García-Jiménez A, Gil-Moreno A. Survival outcomes and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma. Clin Transl Oncol 2021;23:1210-9. [PMID: 33210235 DOI: 10.1007/s12094-020-02512-6] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
14 Zheng Y, Yin Q, Yang X, Dong R. Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series, a population-based analysis and review of the literature. Ann Transl Med 2020;8:1358. [PMID: 33313103 DOI: 10.21037/atm-20-2180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
15 Ferrandina G, Aristei C, Biondetti PR, Cananzi FCM, Casali P, Ciccarone F, Colombo N, Comandone A, Corvo' R, De Iaco P, Dei Tos AP, Donato V, Fiore M, Franchi, Gadducci A, Gronchi A, Guerriero S, Infante A, Odicino F, Pirronti T, Quagliuolo V, Sanfilippo R, Testa AC, Zannoni GF, Scambia G, Lorusso D. Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia). Eur J Cancer 2020;139:149-68. [PMID: 32992154 DOI: 10.1016/j.ejca.2020.08.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wu J, Zhang H, Li L, Hu M, Chen L, Wu S, Xu B, Song Q. Prognostic nomogram for predicting survival in patients with high grade endometrial stromal sarcoma: a Surveillance Epidemiology, and End Results database analysis. Int J Gynecol Cancer 2020;30:1520-7. [PMID: 32839227 DOI: 10.1136/ijgc-2020-001409] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Capozzi VA, Monfardini L, Ceni V, Cianciolo A, Butera D, Gaiano M, Berretta R. Endometrial stromal sarcoma: A review of rare mesenchymal uterine neoplasm. J Obstet Gynaecol Res 2020;46:2221-36. [PMID: 32830415 DOI: 10.1111/jog.14436] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
18 Hodgson A, Swanson D, Tang S, Dickson BC, Turashvili G. Gene fusions characterize a subset of uterine cellular leiomyomas. Genes Chromosomes Cancer 2020. [PMID: 32677742 DOI: 10.1002/gcc.22888] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Wu J, Zhang H, Li L, Hu M, Chen L, Xu B, Song Q. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis. Cancer Commun (Lond) 2020;40:301-12. [PMID: 32558385 DOI: 10.1002/cac2.12067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
20 Nasioudis D, Mastroyannis SA, Latif NA, Ko EM, Haggerty AF, Kim SH, Morgan MA, Giuntoli RL. Effect of bilateral salpingo-oophorectomy on the overall survival of premenopausal patients with stage I low-grade endometrial stromal sarcoma; a National Cancer Database analysis. Gynecologic Oncology 2020;157:634-8. [DOI: 10.1016/j.ygyno.2020.04.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
21 Nasioudis D, Ko EM, Kolovos G, Vagios S, Kalliouris D, Giuntoli RL. Ovarian preservation for low-grade endometrial stromal sarcoma: a systematic review of the literature and meta-analysis. Int J Gynecol Cancer 2019;29:126-32. [PMID: 30640694 DOI: 10.1136/ijgc-2018-000063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
22 Denschlag D, Ackermann S, Battista MJ, Cremer W, Egerer G, Follmann M, Haas H, Harter P, Hettmer S, Horn LC, Juhasz-Boess I, Kast K, Köhler G, Kröncke T, Lindel K, Mallmann P, Meyer-Steinacker R, Mustea A, Petru E, Reichardt P, Schmidt D, Strauss HG, Tempfer C, Thiel F, Ulrich U, Vogl T, Vordermark D, Gass P, Beckmann MW. Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019). Geburtshilfe Frauenheilkd 2019;79:1043-60. [PMID: 31656317 DOI: 10.1055/a-0882-4116] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
23 Cui R, Cao G, Bai H, Zhang Z. The clinical benefits of hormonal treatment for LG-ESS: a meta-analysis. Arch Gynecol Obstet. 2019;300:1167-1175. [PMID: 31583462 DOI: 10.1007/s00404-019-05308-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
24 Wang M, Meng SH, Li B, He Y, Wu YM. Survival outcomes of different treatment modalities in patients with low-grade endometrial stromal sarcoma. Chin Med J (Engl) 2019;132:1128-32. [PMID: 30985313 DOI: 10.1097/CM9.0000000000000259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
25 Rizzo A, Pantaleo MA, Saponara M, Nannini M. Current status of the adjuvant therapy in uterine sarcoma: A literature review. World J Clin Cases 2019; 7(14): 1753-1763 [PMID: 31417921 DOI: 10.12998/wjcc.v7.i14.1753] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
26 Comert GK, Turkmen O, Kar I, Yucel O, Kilic C, Boran N, Basaran D, Karalok A, Turan T. Hormone therapy following surgery in low-grade endometrial stromal sarcoma: Is it related to a decrease in recurrence rate? J Chin Med Assoc 2019;82:385-9. [PMID: 31058712 DOI: 10.1097/JCMA.0000000000000039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
27 Comert GK, Karalok A, Turan T. Reply to "The routine use of progestins might be a good choice for patients with recurrent low-grade endometrial stromal sarcoma after definite surgery". J Chin Med Assoc 2019;82:525. [PMID: 31008813 DOI: 10.1097/JCMA.0000000000000108] [Reference Citation Analysis]
28 McCarthy AJ, Clarke BA, McGilvray I, Dickson BC, Khalili K, Chetty R. Metastatic low-grade endometrial stromal sarcoma of uterus presenting as a primary pancreatic tumor: case presentation and literature review. Diagn Pathol 2019;14:30. [PMID: 31010432 DOI: 10.1186/s13000-019-0807-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Ghirardi V, Bizzarri N, Guida F, Vascone C, Costantini B, Scambia G, Fagotti A. Role of surgery in gynaecological sarcomas. Oncotarget 2019;10:2561-75. [PMID: 31069017 DOI: 10.18632/oncotarget.26803] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
30 Thiel FC, Halmen S. Low-Grade Endometrial Stromal Sarcoma - a Review. Oncol Res Treat. 2018;41:687-692. [PMID: 30317238 DOI: 10.1159/000494225] [Cited by in Crossref: 20] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
31 Chin TH, Lin G, Wu RC, Lai CH. Recurrence after fertility-preserving surgery for low-grade endometrial stromal sarcoma. J Obstet Gynaecol Res 2018;44:1836-42. [PMID: 29974555 DOI: 10.1111/jog.13695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
32 Deshmukh U, Black J, Perez-irizarry J, Passarelli R, Levy K, Rostkowski A, Hui P, Rutherford TJ, Santin AD, Azodi M, Silasi D, Ratner E, Litkouhi B, Schwartz PE. Adjuvant Hormonal Therapy for Low-Grade Endometrial Stromal Sarcoma. Reprod Sci 2018;26:600-8. [DOI: 10.1177/1933719118778801] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
33 Xie W, Cao D, Yang J, Jiang X, Shen K, Pan L, Huang H, Lang J, You Y, Chen J. Fertility-sparing surgery for patients with low-grade endometrial stromal sarcoma. Oncotarget. 2017;8:10602-10608. [PMID: 27736798 DOI: 10.18632/oncotarget.12491] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
34 Hoang L, Chiang S, Lee C. Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations. Pathology 2018;50:162-77. [DOI: 10.1016/j.pathol.2017.11.086] [Cited by in Crossref: 51] [Cited by in F6Publishing: 57] [Article Influence: 12.8] [Reference Citation Analysis]
35 Nasioudis D, Chapman-Davis E, Frey M, Holcomb K. Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma. J Gynecol Oncol 2017;28:e46. [PMID: 28541635 DOI: 10.3802/jgo.2017.28.e46] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
36 Xiu XX, Wang HL, Yun-Yi L, Fan-Dou K, Jin-Ping H. Endometrial stromal sarcoma in combination with mixed type endometrial carcinomas: A case report and literature review. Medicine (Baltimore) 2017;96:e8928. [PMID: 29245257 DOI: 10.1097/MD.0000000000008928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
37 Lou T, Yuan F, Feng Y, Wang S, Bai H, Zhang Z. The safety of fertility and ipsilateral ovary procedures for borderline ovarian tumors. Oncotarget 2017;8:115718-29. [PMID: 29383195 DOI: 10.18632/oncotarget.23021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
38 Agarwal R, Rajanbabu A, Nair IR, Satish C, Jose G, Unikrishnan U. Endometrial stromal sarcoma—A retropsective analysis of factors affecting recurrence. European Journal of Obstetrics & Gynecology and Reproductive Biology 2017;216:92-7. [DOI: 10.1016/j.ejogrb.2017.07.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
39 Xie W, Bi X, Cao D, Yang J, Shen K, You Y. Primary endometrioid stromal sarcomas of the ovary: a clinicopathological study of 14 cases with a review of the literature. Oncotarget 2017;8:63345-52. [PMID: 28968994 DOI: 10.18632/oncotarget.18805] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
40 Cui R, Yuan F, Wang Y, Li X, Zhang Z, Bai H. Clinicopathological characteristics and treatment strategies for patients with low-grade endometrial stromal sarcoma. Medicine (Baltimore). 2017;96:e6584. [PMID: 28403089 DOI: 10.1097/md.0000000000006584] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
41 Horng HC, Wen KC, Wang PH, Chen YJ, Yen MS, Ng HT; Taiwan Association of Gynecology Systematic Review Group. Uterine sarcoma Part II-Uterine endometrial stromal sarcoma: The TAG systematic review. Taiwan J Obstet Gynecol. 2016;55:472-479. [PMID: 27590366 DOI: 10.1016/j.tjog.2016.04.034] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
42 Krentel H, De Wilde RL. Submucous uterine adenosarcoma-minimally invasive treatment. World J Surg Oncol 2016;14:271. [PMID: 27769260 DOI: 10.1186/s12957-016-1015-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
43 Zhang J, Li T, Zhang J, Zhu L, Lang J, Leng J. Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation: . International Journal of Gynecological Cancer 2016;26:456-63. [DOI: 10.1097/igc.0000000000000638] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
44 Si M, Jia L, Song K, Zhang Q, Kong B. Role of Lymphadenectomy for Uterine Sarcoma: A Meta-Analysis. Int J Gynecol Cancer 2016;27:109-16. [DOI: 10.1097/igc.0000000000000842] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
45 Denschlag D, Thiel FC, Ackermann S, Harter P, Juhasz-Boess I, Mallmann P, Strauss HG, Ulrich U, Horn LC, Schmidt D, Vordermark D, Vogl T, Reichardt P, Gaß P, Gebhardt M, Beckmann MW. Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015). Geburtshilfe Frauenheilkd 2015;75:1028-42. [PMID: 26640293 DOI: 10.1055/s-0035-1558120] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
46 Zhou J, Zheng H, Wu SG, He ZY, Li FY, Su GQ, Sun JY. Influence of different treatment modalities on survival of patients with low-grade endometrial stromal sarcoma: A retrospective cohort study. Int J Surg. 2015;23:147-151. [PMID: 26449652 DOI: 10.1016/j.ijsu.2015.09.072] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
47 Laurelli G, Falcone F, Scaffa C, Messalli EM, Del Giudice M, Losito S, Greggi S. Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series and review of the literature. Eur J Obstet Gynecol Reprod Biol. 2015;195:61-66. [PMID: 26476800 DOI: 10.1016/j.ejogrb.2015.09.041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
48 Ali RH, Rouzbahman M. Endometrial stromal tumours revisited: an update based on the 2014 WHO classification. J Clin Pathol. 2015;68:325-332. [PMID: 25595274 DOI: 10.1136/jclinpath-2014-202829] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 8.7] [Reference Citation Analysis]
49 Morimoto A, Tsubamoto H, Inoue K, Ikeda Y, Hirota S. Fatal case of multiple recurrences of endometrial stromal sarcoma after fertility-sparing management: Fatal endometrial stromal sarcoma. J Obstet Gynaecol Res 2015;41:162-6. [DOI: 10.1111/jog.12506] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]